A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild Hyperglycemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00300287
Recruitment Status : Completed
First Posted : March 8, 2006
Last Update Posted : August 2, 2017
Information provided by:

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 26, 2007
  Actual Study Completion Date : June 26, 2007